|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.520 EUR | -8.61% |
|
-22.91% | +219.08% |
| 06/07 | Carvolix Presents Clinical Data on TAVIPILOT Platform At New York Valves 2026 | CI |
| 24/06 | French Medical Technology Company Carvolix Plans EUR10 Million Share Offering | MT |
| Market Cap | 37Cr 33Cr 30Cr 28Cr 52Cr 3.6TCr 53Cr 361.45Cr 141.69Cr 1.76TCr 140.1Cr 137.04Cr 6.07TCr | P/E 2025 * |
-12.5x | P/E 2026 * | -12x |
|---|---|---|---|---|---|
| Enterprise Value | 40Cr 35Cr 32Cr 30Cr 56Cr 3.87TCr 57Cr 388.39Cr 152.25Cr 1.89TCr 150.54Cr 147.26Cr 6.52TCr | EV / Sales 2025 |
-
| EV / Sales 2026 * | 269x |
| Free-Float |
25.37% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -8.61% | ||
| 1 week | -22.91% | ||
| Current month | +59.54% | ||
| 1 month | +55.93% | ||
| 3 months | +79.22% | ||
| 6 months | +204.97% | ||
| Current year | +219.08% |
| 1 week | 5.4 | 6.7 | |
| 1 month | 3.21 | 7.56 | |
| Current year | 1.73 | 7.56 | |
| 1 year | 1.18 | 7.56 | |
| 3 years | 0.93 | 7.56 | |
| 5 years | 0.93 | 7.56 | |
| 10 years | 0.93 | 8.6 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/10/25 | Truffle Capital SAS
| Buy | Company | 16,176 | 0.0411% | |
| 27/09/25 | Truffle Capital SAS
| Buy | Company | 18,382 | 0.0467% | |
| 06/02/24 | Truffle Capital SAS
| Buy | Company | 14,19,871 | 4.5955% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.61% | -22.91% | +338.10% | +377.92% | 41Cr | ||
| -0.10% | -0.29% | +38.04% | +3.97% | 1.25TCr | ||
| -0.22% | +10.37% | +15.54% | +20.68% | 657Cr | ||
| -0.28% | -2.12% | +59.03% | +26.88% | 583.23Cr | ||
| -0.06% | +5.09% | - | - | 475.47Cr | ||
| +7.86% | +6.28% | -24.06% | +26.14% | 425.11Cr | ||
| +1.80% | +5.55% | -20.95% | -20.32% | 401.74Cr | ||
| +0.13% | -0.93% | -0.50% | -58.70% | 184.39Cr | ||
| -1.63% | -5.33% | -6.07% | +253.63% | 180.49Cr | ||
| +1.15% | +2.49% | +61.94% | -2.06% | 156Cr | ||
| Average | +0.00% | -0.37% | +51.23% | +69.79% | 435.64Cr | |
| Weighted average by Cap. | +0.73% | +2.75% | +24.72% | +22.49% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | - | 15.83L 13.87L 12.83L 11.8L 22.26L 15Cr 22.61L 1.53Cr 60.12L 7.47Cr 59.44L 58.15L 26Cr |
| Net income | -2.21Cr -1.94Cr -1.79Cr -1.65Cr -3.1Cr -212.96Cr -3.15Cr -21Cr -8.39Cr -104.2Cr -8.29Cr -8.11Cr -359Cr | -3.31Cr -2.9Cr -2.68Cr -2.47Cr -4.66Cr -319.52Cr -4.73Cr -32Cr -13Cr -156.34Cr -12Cr -12Cr -538.63Cr |
| Net Debt | 2.78Cr 2.44Cr 2.25Cr 2.07Cr 3.91Cr 268.14Cr 3.97Cr 27Cr 11Cr 131.2Cr 10Cr 10Cr 452.01Cr | 5.27Cr 4.62Cr 4.27Cr 3.93Cr 7.41Cr 508.09Cr 7.53Cr 51Cr 20Cr 248.6Cr 20Cr 19Cr 856.52Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | €5.520 | -8.61% | 53,509 |
| 17/26/17 | €6.040 | +7.86% | 42,155 |
| 16/26/16 | €5.600 | -11.95% | 49,864 |
| 15/26/15 | €6.360 | -0.63% | 92,826 |
| 14/26/14 | €6.400 | -10.61% | 88,547 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Annual profits - Rate of surprise
- Stock Market
- Stocks
- CVX Stock
Select your edition
All financial news and data tailored to specific country editions
















